Ablynx to present data on its anti-IL-6R Nanobody, developed in partnership with Abbvie

Ablynx announced that it will present two posters on its novel anti-IL-6R Nanobody®, ALX-0061, at the 2014 American College of Rheumatology (ACR/ARHP) Annual Meeting, which is taking place from 14 to 19 November 2014 in Boston, MA, USA.

Source: Pharmacy Europe - November 14, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Rheumatology ACR 2014 ALX-0061 IL-6R Nanobody Latest News rheumatoid arthritis Source Type: news